Clene announced that it will effect a 1-for-20 reverse stock split at 12:01 a.m. Eastern Time, on July 11, 2024. Beginning with the opening of trading on July 11, 2024, Clene’s common stock will trade on the Nasdaq Capital Market on a split-adjusted basis under a new CUSIP number 185634201 and the Company’s existing trading symbol “CLNN.” The CUSIP number for the Company’s publicly traded warrants will not change. The reverse stock split is intended to enable Clene to regain compliance with the $1.00 minimum closing bid price required for continued listing on the Nasdaq Capital Market.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLNN:
- Clene Announces 1-for-20 Reverse Stock Split
- Clene to Present at H.C. Wainwright’s 5th Annual Neuro Perspectives Virtual Conference
- Clene presents preliminary data on CNM-Au8 in Rett Syndrome
- Clene Presents Preliminary Data for CNM-Au8® as a Potential Treatment for Rett Syndrome
- Clene Reveals Breakthrough ALS Trial Results and Extended Survival Data